These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29098898)

  • 1. The pharmacological treatment of acute HIV infections in neonates.
    Kuhn L; Shiau S
    Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1353-1361. PubMed ID: 29098898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.
    Clarke DF; Penazzato M; Capparelli E; Cressey TR; Siberry G; Sugandhi N; Mirochnick M;
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):83-93. PubMed ID: 29039686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very early combination antiretroviral therapy in infants: prospects for cure.
    Rainwater-Lovett K; Luzuriaga K; Persaud D
    Curr Opin HIV AIDS; 2015 Jan; 10(1):4-11. PubMed ID: 25402708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges.
    Technau KG; Kuhn L; Coovadia A; Carmona S; Sherman G
    J Int AIDS Soc; 2017 Apr; 20(1):21436. PubMed ID: 28406596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiviral agents for reduction of mother-to-child transmission of HIV infection].
    Bruun JN
    Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2041-2. PubMed ID: 12934126
    [No Abstract]   [Full Text] [Related]  

  • 7. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
    Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
    Sante; 1997; 7(2):115-25. PubMed ID: 9273118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS; Read JS
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study.
    Ruel TD; Capparelli EV; Tierney C; Nelson BS; Coletti A; Bryson Y; Cotton MF; Spector SA; Mirochnick M; LeBlanc R; Reding C; Zimmer B; Persaud D; Bwakura-Dangarembizi M; Naidoo KL; Hazra R; Jean-Philippe P; Chadwick EG
    Lancet HIV; 2021 Mar; 8(3):e149-e157. PubMed ID: 33242457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vertical transmission of HIV in Denmark].
    Kvinesdal BB; Valerius NH; Herlin T; Hansen IM; Hornstrup MK; Christensen HO; Nielsen HI; Olofsson MJ
    Ugeskr Laeger; 2002 Nov; 164(47):5495-7. PubMed ID: 12523022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Viral and Immune Interplay During Vertical Transmission of HIV: Implications for Cure.
    Amin O; Powers J; Bricker KM; Chahroudi A
    Front Immunol; 2021; 12():757400. PubMed ID: 34745130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the prevention of vertical transmission of human immunodeficiency virus.
    Mofenson LM
    Semin Pediatr Infect Dis; 2003 Oct; 14(4):295-308. PubMed ID: 14724794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
    Mirochnick M; Best BM; Clarke DF
    Clin Perinatol; 2010 Dec; 37(4):907-27, xi. PubMed ID: 21078458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevirapine Pharmacokinetics in Neonates Between 25 and 32 Weeks Gestational Age for the Prevention of Mother-to-Child Transmission of HIV.
    Hirt D; Kubota Kilengelela J; Jarreau PH; Tréluyer JM; Marcou V
    Pediatr Infect Dis J; 2021 Apr; 40(4):344-346. PubMed ID: 33710978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.
    Bhoopat L; Khunamornpong S; Lerdsrimongkol P; Sirivatanapa P; Sethavanich S; Limtrakul A; Gomutbuthra V; Kajanavanich S; Thorner PS; Bhoopat T
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):545-50. PubMed ID: 16284530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe.
    Dinh TH; Mushavi A; Shiraishi RW; Tippett Barr B; Balachandra S; Shambira G; Nyakura J; Zinyowera S; Tshimanga M; Mugurungi O; Kilmarx PH
    Clin Infect Dis; 2018 Feb; 66(4):576-585. PubMed ID: 29401270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.